Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

Research output: Contribution to journalArticle

Abstract

To define disease activity levels, minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) disease activity indexes: European League Against Rheumatism (EULAR) SS disease activity index (ESSDAI) and EULAR SS patient-reported index (ESSPRI).

Details

Authors
  • Raphaèle Seror
  • Hendrika Bootsma
  • Alain Saraux
  • Simon J Bowman
  • Johan G Brun
  • Gabriel Baron
  • Véronique Le Guern
  • Valérie Devauchelle-Pensec
  • Manel Ramos-Casals
  • Valeria Valim
  • Thomas Dörner
  • Athanasios Tzioufas
  • Jacques-Eric Gottenberg
  • Roser Solans Laqué
  • Eric Hachulla
  • Kathy L Sivils
  • Wan-Fai Ng
  • Anne-Laure Fauchais
  • Stefano Bombardieri
  • Roberta Priori
  • Elena Bartoloni
  • Vincent Goeb
  • Sonja Praprotnik
  • Takayuki Sumida
  • Sumusu Nishiyama
  • Roberto Caporali
  • Aike A Kruize
  • Cristina Vollenweider
  • Philippe Ravaud
  • Petra Meiners
  • Pilar Brito-Zerón
  • Claudio Vitali
  • Xavier Mariette
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Rheumatology and Autoimmunity
Original languageEnglish
Pages (from-to)382-389
JournalAnnals of the Rheumatic Diseases
Volume75
Issue number2
Publication statusPublished - 2016
Publication categoryResearch
Peer-reviewedYes